Anonymous
Guest
Anonymous
Guest
I've always been discusted by this companies greed ... even in HIV. You have Atripla and you come up with the Stribild just to make the extra 10K. Now they have the opportunity to make a real dent in one of the world's most disabling diseases and they sit at the food trof stuffing their faces.
So glad to see that the world see's you for what you are and I hope the stock takes a nose dive to reward you for your efforts ...
Oh yeah ... efforts. Lets see you continuously buy out companies and reformulate old drugs (Atripla) to make them more convenient for the public but you never develop anything original ... and you call that innovation. How about developing your own molecule and bringing it to market ... "you used care salesman"
I'm getting into the Hep C market on the opposing side and my main motivation will be to kick this companies ass.
So glad to see that the world see's you for what you are and I hope the stock takes a nose dive to reward you for your efforts ...
Oh yeah ... efforts. Lets see you continuously buy out companies and reformulate old drugs (Atripla) to make them more convenient for the public but you never develop anything original ... and you call that innovation. How about developing your own molecule and bringing it to market ... "you used care salesman"
I'm getting into the Hep C market on the opposing side and my main motivation will be to kick this companies ass.